Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms 1 Hearing Loss 1

Interventions

pembrolizumab 1254 Specimen Handling 869 Carboplatin 818 Magnetic Resonance Spectroscopy 804 Cyclophosphamide 795 Cisplatin 716 Nivolumab 648 Paclitaxel 623 Radiotherapy 567 Gemcitabine 565 Biopsy 529 Bevacizumab 468 Dexamethasone 434 fludarabine 404 Docetaxel 373 venetoclax 366 Oxaliplatin 362 Capecitabine 353 Fluorouracil 352 atezolizumab 341 Rituximab 327 durvalumab 326 Doxorubicin 313 Radiosurgery 306 Pemetrexed 303 Drug Therapy 295 Standard of Care 292 Ipilimumab 290 Etoposide 280 Radiation 278

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hearing Tests × 1 year × Clear all

NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed

Ototoxicity, Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡